Stimulation of protective and cross-protective immunity against influenza B virus after adjuvant mucosal immunization of mice

Folia Microbiologica

Volumn 54, Issue 6, 2009, Pages 549-552

  Prokesova L ^a   Zanvit P ^a   Havlickova M ^b   Tacner J ^b   Jirkovska M ^a   Petraskova P ^a   Novotna O ^a   Cechova D ^a   Julak J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLUS FIRMUS; INFLUENZA B VIRUS; INFLUENZAVIRUS B; MUS; ORTHOMYXOVIRIDAE;

IMMUNOLOGICAL ADJUVANT; INACTIVATED VACCINE; INFLUENZA VACCINE;

ANIMAL; ARTICLE; BACILLUS; BAGG ALBINO MOUSE; CROSS PROTECTION; FEMALE; IMMUNIZATION; IMMUNOLOGY; INFLUENZA VIRUS B; INHALATIONAL DRUG ADMINISTRATION; METHODOLOGY; MOUSE; ORTHOMYXOVIRUS INFECTION; SURVIVAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INHALATION; ANIMALS; BACILLUS; CROSS PROTECTION; FEMALE; IMMUNIZATION; INFLUENZA B VIRUS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; VACCINES, INACTIVATED;

EID: 77950913173     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12223-009-0080-z     Document Type: Article

References (11)

1. ASAHI-OZAKI Y., YOSHIKAWA T., IWAKURA Y., SUZUKI Y., TAMURA S., KURATA T., SATA T.: Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus. J.Med. Virol. 74, 328-335 (2004).
2. CAMILLONI B., NERI M., LEPRI E., IORIO A.M.: Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages. Vaccine 27, 4099-4103 (2009).
3. GUY B.: The perfect mix: recent progress in adjuvant research. Nat.Rev.Microbiol. 5, 505-517 (2007).
4. HUBER V.C, KLEIMEYER L.H., MCCULLERS J.A.: Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus. Vaccine 26, 5381-5388 (2008).
5. KAMPS B.S., HOFFMANN CH., PREISER W.: Influenza Report 2006. Amedeo Flying Publisher, Wuppertal (Germany) 2006.
6. MLCKOVA P., CECHOVA D., CHALUPNA P., NOVOTNA O., PROKESOVA L.: Enhanced systemic and mucosal antibody responses to a model protein antigen after intranasal and intratracheal immunisation using Bacillus firmus as an adjuvant. Immunol.Lett. 77, 39-45 (2001).
7. SHEN J., KIRK B.D., MA J., WANG Q.: Diversifying selective pressure on influenza B virus hemagglutinin. J.Med. Virol. 81, 114-124 (2009).
8. TAMURA S., TANIMOTO T., KURATA T.: Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines. Japan.J.Infect.Dis. 58, 195-207 (2005).
9. WEBBY R.J., ANDREANSKY S., STAMBAS J., REHG J.E., WEBSTER R.G., DOHERTY P.C, TURNER S.J.: Protection and compensation in the influenza virus-specific CD8+ T cell response. Proc.Nat.Acad.Sci.USA 100, 7235-7240 (2003).
10. ZANVIT P., HAVLICKOVA M., TACNER J., JIRKOVSKA M., PETRASKOVA P., NOVOTNA O., CECHOVA D., JULAK J., STERZL I., PROKESOVA L.: Immune response after adjuvant mucosal immunization of mice with inactivated influenza virus. Immunol.Lett. 97, 251-259 (2005).
11. ZANVIT P., HAVLICKOVA M., TACNER J., NOVOTNA O., JIRKOVSKA M., CECHOVA D., JULAK J., STERZL I., PROKESOVA L.: Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant. Immunol.Lett. 115, 144-152 (2008).